Laddar...

The clinical potential of inotuzumab ozogamicin in relapsed and refractory acute lymphocytic leukemia

Antibody–drug conjugates (ADCs) are likely to make a significant contribution in the treatment of acute lymphoblastic leukemia (ALL) by combining the cytotoxicity of chemotherapy with the specificity of monoclonal antibodies. CD22, an endocytic receptor expressed by the majority of B cells, is an ex...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ther Adv Hematol
Huvudupphovsmän: Yilmaz, Musa, Richard, Samantha, Jabbour, Elias
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2015
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4556970/
https://ncbi.nlm.nih.gov/pubmed/26425338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620715596715
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!